Author:
Kim Esther S.H.,Gornik Heather L.
Reference127 articles.
1. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial;Gonzales;JAMA,2006
2. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary;Respir Care,2008
3. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial;Jorenby;JAMA,2006
4. Clinical practice. Treatment of tobacco use and dependence;Rigotti;N Engl J Med,2002
5. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;1:CD000146.